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Abstract 
The mRNA cap structure, which is added to nascent RNA pol II transcripts, recruits the 
protein complexes required for pre-mRNA transcript processing, mRNA export and 
translation initiation.  The enzymes which catalyse mRNA cap synthesis are regulated by 
cellular signaling pathways which impact on their expression, localisation and activity. 
Here we discuss the recent observation that the mRNA cap methyltransferase, RNMT, is 
phosphorylated on Thr-77 by CDK1-cyclin B1, which regulates its activity and the 
proteins with which it interacts.  RNMT Thr-77 phosphorylation provides a burst of 
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mRNA cap methyltransferase activity during early G1 phase at a time when transcription 
is reactivated following completion of the cell cycle.  This co-ordination of transcription 
and mRNA capping makes an important contribution to gene expression in the cell; 
preventing RNMT Thr-77 phosphorylation inhibits cell proliferation.  Here we discuss 
these findings and how mRNA cap synthesis may be regulated in other scenarios. 
3 
Introduction 
Eukaryotic cells contain a variety of RNA molecules, the vast majority of which assist 
with mRNA processing and translation including ribosomal RNA and transfer RNA.  
Transcripts which mature to become protein-encoding messenger RNA (mRNA) only 
account for about 5% all cellular transcripts.  The mRNA cap, a modification added to 
the first transcribed nucleotide of pre-mRNA and other RNA pol II transcripts, flags these 
RNAs for appropriate processing, nuclear export and translation into protein 
1-3
.  The 
structure of the mRNA cap also protects transcripts from exonucleases.  The importance 
of the mRNA cap for gene expression was recognised shortly after its discovery by a 
series of experiments in vitro and in yeast.  More recently formation and degradation of 
the mRNA cap has been observed to be regulated by cellular signalling pathways in 
mammalian cells 
4,5
. 
The mRNA cap consists of a 7-methylguanosine group linked via a 5’ to 5’ triphosphate 
bridge to the first transcribed nucleotide of RNA pol II transcripts (Figure 1) 
2,3
.  The first 
few nucleotides can also be methylated, but the position and extent of methylation varies 
between species.  Transcripts are synthesised with a 5’ triphosphate on the first 
transcribed nucleotide to which the mRNA cap is added by the action of a series of 
enzymes 
1,4
.  In mammals the basic mRNA cap structure, cap 0, is formed by the 
sequential action of CE/RNGTT and RNMT-RAM, two enzymes recruited to 
phosphorylated RNA pol II at the initiation of transcription.  CE/RNGTT has 
triphosphatase and guanylyltransferase activities which cleave the transcript terminal 
4 
phosphate and catalyse addition of guanosine monophosphate, to form the cap structure, 
G(5’)ppp(5’)N (N is the first transcribed nucleotide).  Subsequently, RNMT-RAM 
catalyses N-7 methylation of the guanosine cap to create, m7G(5’)ppp(5’)N.  This cap 0 
structure is functional in recruiting the Cap-binding complex (CBC) and the eukaryotic 
initiation factor 4E, eIF4E, and other factors which promote transcript splicing, export 
and translation initiation 
5,6
.  Furthermore, in mammals the first two nucleotides are 
methylated on the O-2 position by CMTR1 and CMTR2 
7,8
.  O-2 methylation has roles in 
translation initiation and identifying transcripts as “self” in innate immunity 4.   
Regulation of mRNA cap methylation 
The mammalian mRNA cap methyltransferase, RNMT-RAM, consists of the enzymic 
subunit, RNMT (RNA guanine-7 methyltransferase) and the activator subunit, RAM 
(RNMT-activating miniprotein) 
9,10
.  RNMT has a catalytic core, which is homologous in 
structure and function to other eukaryotic cap methyltransferases 
11
.  In addition, RNMT 
contains an N-terminal non-catalytic domain, which is conserved in mammals but not in 
other eukaryotes (Figure 2) 
9
.   S.cerevisiae null for the cap methyltransferase are inviable 
and can be rescued by the expression of murine RNMT catalytic domain
12
.  RAM 
activates RNMT by altering the position of key active site residues, increasing methyl 
donor binding 
11
.  RAM also has a high-affinity RNA binding domain which may 
increase the rate of recruitment of transcripts in general or may have specificity for 
particular transcript motifs 
10,13
  
5 
In human cells, RNMT-RAM is recruited via the N-terminal domain of RNMT to RNA 
pol II proximal to transcription initiation sites 
14,15
.  The RNMT N-terminal domain also 
impacts on cap methyltransferase activity.  Its removal increases catalytic activity, 
suggesting that this domain may have some regulatory function.  We questioned whether 
RNMT could be regulated by N-terminal domain post-translational modifications or 
interacting proteins, which could potentially change the conformation or action of the N-
terminus. To address this question we performed proteomic analyses to map post-
translational modifications of RNMT 
16,17
.   
Our mass spectrometry analysis performed in HEK293 cells identified several 
phosphorylated, methylated and acetylated residues (Figure 2) 
16
 (VHC/MA unpublished 
observations).  All of the phosphorylation sites, along with others, were also indicated in 
the PhosphositePlus database, which contains data from high-throughput phospho-
proteomic experiments from many research groups (Figure 2) 
17
.  Interestingly, the 
RNMT post-translational modifications were predominantly found in the N-terminus of 
RNMT and not in the catalytic domain.  Sites of post-translational modification that arose 
in the catalytic domain may have been detrimental to activity and suppressed during 
evolution.  The mammalian RNMT N-terminal domain may have evolved in order to 
allow regulation of cap methylation by signaling pathways.  The phosphorylation sites 
found in the N-terminus cover a range of different amino acid motifs suggesting that 
several different kinases act on RNMT.  Furthermore, the different methylation and 
acetylation events identified in our study demonstrate that several types of enzyme can 
modify RNMT.  Therefore, the RNMT N-terminus is receiving a range of signaling 
6 
information from different pathways, some of which may be regulating RNMT and thus 
formation of the mRNA cap. 
Regulation and function of RNMT T77 phosphorylation 
In HeLa cells, Thr-77 is the predominant site of phosphorylation.  We have also observed 
RNMT Thr-77 phosphorylation in embryonic stem cells, mammary epithelial cells, T 
lymphocytes and HEK293 cells 
16
 (VHC lab unpublished observations).  RNMT Thr-77 
is present in a CDK (cyclin-dependent kinase) recognition site adjacent to a cyclin 
binding site.  The cell cycle is governed by the sequential activation of different CDK-
cyclin complexes.  RNMT Thr-77 phosphorylation levels oscillate throughout the cell 
cycle with highest phosphorylation levels during late S phase, through G2/M phase and 
into early G1 phase.  The major kinase operational during these phases is CDK1-cyclin 
B1, although other CDK-cyclins are active at this time.  We provided evidence in cells 
and in vitro that CDK1-cyclin B1 can phosphorylate RNMT directly.  However, other 
CDK-cyclins may also phosphorylate RNMT Thr-77 and other proline-directed kinases 
RNMT Thr-77 phosphorylation directly increases cap methyltransferase activity 
16
. 
Presumably phosphorylation reverses some of the inhibitory effects of the N-terminal 
domain.  The structure of the RNMT N-terminus has not been solved limiting molecular 
insight into Thr-77 function.  Following reformation of the nuclear envelope after mitosis, 
factors involved in transcription are reassembled on chromatin and transcription initiates.  
Thus CDK1-dependent Thr-77 phosphorylation co-ordinates the peak of RNMT cap 
7 
methyltransferase activity with transcription initiation.  Furthermore, high levels of 
transcripts carrying the mRNA cap may also contribute to the increase in cap-dependent 
translation that is observed during the initiation of G1 phase 
18
. 
The mRNA cap binds to factors involved in transcription, processing and translation, and 
also protects the transcript from exonucleases 
4
.   However, the precise role of the mRNA 
cap on these different gene expression processes on a genome-wide level is only 
beginning to be documented in mammalian cells.  Mutation of RNMT Thr-77 to alanine 
(T77A) which blocks phosphorylation did not have a detectable effect on transcript level, 
despite significant depth of RNA sequencing analysis 
16
. However, the T77A mutation 
did inhibit the expression of a subset of proteins, and inhibited cell proliferation.  
Although RNMT Thr-77 phosphorylation is cell cycle-dependent, the proteins whose 
expression is dependent on this modification were not found to be associated with 
synthesis at a specific stage of the cell cycle.  It is important to highlight that this gene 
expression analysis was performed in unsynchronized cells and therefore a small effect 
on transcript levels during a specific phase of the cell cycle may have been undetected. 
RNMT has a relatively long half-life in cells investigated to date (over 12 hours) (VHC 
lab unpublished observations).  Therefore, the observation that RNMT Thr-77 
phosphorylation is lost rapidly during G1 phase is likely to be the result of a rapidly 
acting phosphatase.  The identity of the phosphatase or phosphatases involved is not 
known but a change in the activity or expression of these enzymes has the power to alter 
8 
Does RNMT Thr-77 have other functions? 
Although RNMT Thr-77-dependent phosphorylation has a role in co-ordinating 
transcription and mRNA cap methylation during early G1, it is also highly 
phosphorylated at the end of S phase and through G2/M 
16
.  Although the majority of 
gene expression occurs during G1 phase of the cell cycle, translation has been described 
to occur at other phases including during mitosis 
19,20
.  It may be that in certain 
circumstances, in particular cell lineages, the increase in mRNA cap methyltransferase 
activity driven by RNMT Thr-77 phosphorylation is needed to drive the expression of a 
subset of transcripts during late S or G2/M phase. 
RNMT is imported into the nucleus following synthesis or after mitosis by interaction 
with importin-alpha 
21,22
.  Three classical lysine-rich nuclear localisation signals lie in the 
RNMT N-terminus.  Although we observed that phosphorylation of RNMT Thr-77 
suppresses RNMT interaction with importin-alpha, in HeLa cells nuclear import of the 
RNMT T77A mutant or T77D mutant (phosphor mimic mutation) was not altered 
16
.  
RAM carries a nuclear localization signal and thus in the presence of Thr-77 
phosphorylation RNMT may rely on its interaction with RAM for nuclear import 
12.
  
However, it may be that in certain situations Thr-77 phosphorylation regulates RNMT 
We observed that importin-alpha inhibits RNMT activity. If RNMT has a role in 
methylating mature cytoplasmic transcripts, T77 phosphorylation-dependent inhibition of 
importin-alpha binding would increase cytoplasmic cap methyltransferase activity, which 
9 
may have a positive effect on gene expression 
23,24
.  This role could be particularly 
relevant when the nuclear envelope breaks down during mitosis and RNMT is dispersed 
into the cytoplasm.  Increased RNMT activity and delocalisation from importin-alpha 
may be required for RNMT to function when it is dissociated from chromatin. 
RNMT Thr-77 phosphorylation specificity 
In HeLa cells, blocking RNMT Thr-77 phosphorylation did not affect the expression of 
all genes equally 
16
.  What is the nature of the specificity? Why are only certain genes 
dependent on RNMT Thr-77 phosphorylation?  As with all enzymes, specificity comes 
from either the enzyme itself or from the availability of the substrate.  RNMT Thr-77 is 
in the N-terminus, the domain that interacts with RNA pol II (probably indirectly) 15.  
However, no differential recruitment of RNMT wild type and the T77A mutant was 
observed by chromatin immunoprecipitation performed on candidate genes.  It remains a 
possibility that RNMT Thr-77 phosphorylation influences transcript recruitment in a 
gene-specific manner.  Sequence motifs and structures in the 5’ untranslated region of 
mRNAs may contribute to sensitivity to RNMT phosphorylation.  Thus, analysis of the 
transcripts bound by RNMT/RAM using CLIP-Seq, or a more thorough analysis of the 
changes in translation rates of specific mRNAs using ribosome profiling/Ribo-Seq during 
specific stages of the cell cycle may provide further insights into the specificity of RNMT 
Future perspectives 
10 
mRNA capping is now established as a gene expression mechanism which integrates 
cellular signaling pathways, resulting in reshaping of the gene expression landscape and 
alterations in cell physiology and fate. Transcription factors upregulate RNA pol II 
phosphorylation and methionine metabolism resulting in gene-specific regulation of 
mRNA cap methylation 
25-28
.  Furthermore, embryonic stem cell differentiation requires 
ERK1/2-dependent phosphorylation of RAM, which triggers its degradation and loss of 
pluripotency associated gene expression 
29
.  It seems likely that many other signaling 
pathways will be regulating mRNA capping enzymes.  The challenge going forward is to 
understand the role of mRNA capping regulation on a gene-specific level and how it 
impacts on mammalian development and disease. 
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Figure 1 mRNA cap structure and mRNA capping enzymes 
Structure of mRNA cap and action of mRNA capping enzymes. 
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Figure 2 Post-translational modifications of RNMT 
Human RNMT 1-120 is the N-terminal domain and RNMT 121-476 is the catalytic 
domain and interacts with RAM.  Above depiction of RNMT are phosphorylation sites 
(P) obtained from PhosphositePlus (sites with only 1 mass spectrometry/high-throughput 
proteomics reference excluded). Below depiction of RNMT are phosphorylation, 
acetylation (Ac) and methylation (Me) sites identified from analysis in Aregger et al., 
2016. 
